Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04764071
Other study ID # MD 06 /2020
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date February 28, 2021
Est. completion date June 1, 2022

Study information

Verified date February 2021
Source Ain Shams University
Contact Ashraf Satour, Master degree of Urology
Phone 01000396284
Email ahsrafsatour@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Renal stones are one of the most common urological problems and there are multiple methods for their management such as percutaneous nephrolithotomy, mini and ultra-mini percutaneous nephrolithotomy, flexible ureteroscopy and laser lithotripsy, and extracorporeal shock wave lithotripsy. percutaneous nephrolithotomy is the treatment of choice for the management of renal calculi, in spite of the increasing stone clearance rate, the complication rate of this procedure is relatively higher.


Description:

Nephrolithiasis is a major worldwide source of morbidity, constituting a common urological disease affecting 10-15% of the world population. Consistent technical advancements provide surgeons and patients with several options for the treatment of renal calculi, including extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), retrograde intrarenal surgery (RIRS), and conventional open surgery. Percutaneous nephrolithotomy (PCNL) is generally considered a gold standard in renal stones particularly larger than 2cm or lower calyceal larger than 1cm offering high stone-free rates after the first treatment as compared to the other minimal invasive lithotripsy techniques. Percutaneous nephrolithotripsy (PCNL)is a procedure to remove kidney stones from the kidney through a small incision in the skin and it was initially described in the literature by Fernström and Johansson in 1976. Traditionally, the prone position was considered the only position to obtain renal access for PCNL. In 1987, Valdivia Urìa presented the supine PCNL. PCNL is also recommended in the case of smaller stones in patients with contraindications for shockwave lithotripsy (SWL), such as shockwave resistant stones and anatomical malformations, or when a patient elects PCNL as a procedure of higher efficacy. However, serious complications although rare should be expected following this percutaneous procedure as, Perioperative bleeding, urine leakage from nephrocutaneous tract, pelvicalyceal system injury, pain.( Kyriazis et al 2015) colon injury, hydrothorax, pneumothorax, prolonged leak, sepsis, ureteral stone, vascular injury and acute loss of kidney, all are individually confronted complications after PCNL. PCNL techniques include: standard PCNL (S-PCNL), mini-PCNL (also called miniperc), ultra-mini-PCNL (UM-PCNL) and the recently introduced micro-PCNL. One of the most important differences between the various PCNL techniques is the size of renal access, which contributes to the broad spectrum of complications and outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 1, 2022
Est. primary completion date February 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult patient aged over 18 with renal stone between 1 and 2 cm Exclusion Criteria: 1. patient with a single kidney. 2. Renal stones larger than 2 cm or less than 1 cm. 3. Patients with uncontrolled co-morbidities (hypertension, diabetes mellitus, cardiac disease, chest disease). 4. Patients with active urinary tract infection. 5. Patients with other anatomic renal abnormalities (congenital renal malformations such as horseshoe kidney, polycystic kidney disease, etc.). and Patients with severe skeletal deformity. 6. Pregnant women. 7. Patients with Uncorrectable bleeding disorder. 8. Patients who underwent renal transplantation or urinary diversion

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
percutaneous nephrolithotomy
percutaneous access of the desired calyx is achieved under fluoroscopic guidance with the use of an 18-gauge needle and a guidewire passage. Tract dilation is accomplished by using Amplatz dilators up to 30F.
ultra-mini percutaneous nephrolithotomy
percutaneous access of the desired calyx is achieved under fluoroscopic guidance with the use of an 18-gauge needle and a guidewire passage. Tract dilation is accomplished by using Amplatz dilators up to 12-14 F fascial dilator was used to dilate the nephrostomy tract to pass the 13 F semi-rigid plastic sheath.

Locations

Country Name City State
Egypt Ain Shams University hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary stone free rate of patients with renal stones by non contrast CT scan efficacy of the procedure to clear renal stones completely in single session, non contrast CT will evaluate the stone burden and compare it to the preoperative measurement first day postoperative
Secondary operative time of both procedures time of each procedure in minutes from the lithotomy positioning till completion of the procedure intraoperative finding
Secondary hospital stay of the patient duration till patient is discharged in days 1 to 3 days postoperative
Secondary hemoglobin drop of the patients decrease in the hemoglobin level in comparison to the preoperative results first day postoperative
Secondary postoperative urine leakage from the surgical wound urine leakage from the nephrostomy site if it present or not as document during surgical dressing by the attending physician first day postoperative
Secondary cost analysis of both procedure cost of each procedure including operative cost and postoperative stay in Egyptian Pound 3 days postoperative
See also
  Status Clinical Trial Phase
Completed NCT05340075 - Staged Bilateral Percutaneous Nephrolithotomy
Completed NCT05340088 - Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Completed NCT06381206 - Silodosin in Management of Lower Ureteral Stones Phase 1/Phase 2
Completed NCT05183269 - Virtual Reality for Pain Control During Extracorporeal Shock Wave Lithotripsy: a Prospective, Comparative, Randomized Study at a Single Institution N/A
Completed NCT05646069 - Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi N/A
Not yet recruiting NCT06436235 - Kidney Stone Inflammation
Completed NCT05413603 - Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization N/A
Enrolling by invitation NCT06394908 - Registry of MIUS for Urolithiasis (ReMIUS-U)
Recruiting NCT05535816 - Accuracy of Ultrasound for Detecting Residual Fragments During RIRS N/A
Recruiting NCT05460559 - Endoscopic Combined Intrarenal Surgery Versus Multi-Tract Percutaneous Nephrolithotomy for Complex Renal Stones: N/A
Completed NCT03567421 - Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
Recruiting NCT05866081 - Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative N/A
Completed NCT04594161 - Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis N/A
Not yet recruiting NCT03771365 - Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone
Completed NCT06031103 - Clinical Efficacy of Mini-PCNLversus RIRS for the Management of Upper Urinary Tract Calculus (1-2.5 cm) N/A
Active, not recruiting NCT05759767 - The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis N/A
Not yet recruiting NCT04650737 - Single-Shot With Dexmedetomidine Versus Continuous Ultrasound-guided Erector Spinae Plane Block for Postoperative Pain Control After Percutaneous Nephrolithotomy N/A
Active, not recruiting NCT05389982 - Mobile Health Platform for Surveillance of Kidney Stone N/A
Completed NCT03388060 - (SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone N/A